As of Oct 20
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 3.38, with a high estimate of 4.50 and a low estimate of 2.25. The median estimate represents a +85.44% increase from the last price of 1.82.
The current consensus among 2 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.